ArticleVeterinary research communications2026
Molecular epidemiology of ESBL-producing Escherichia coli causing clinical and subclinical bovine mastitis: associations between multidrug resistance, virulence genes, and phylogroups.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Insights Into the Phylogenetic Diversity, Virulence Determinants, and Antimicrobial Resistance Pattern ofVeterinary medicine international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli are increasingly implicated in bovine mastitis and may serve as a reservoir of antimicrobial resistance with public health relevance. This study aimed to characterize the antimicrobial resistance, ESBL gene distribution, virulence-associated genes, integron carriage, and phylogenetic backgrounds of ESBL-producing E.coli isolated from bovine mastitis, and to compare these features between clinical and subclinical cases. A total of 400 bovine mastitis milk samples collected between June 2024 and May 2025 were screened for ESBL-producing bacteria, followed by phenotypic confirmation and antimicrobial susceptibility testing. Molecular characterization targeted the major ESBL genes, bla CTX−M, blaTEM, and bla SHV, class 1 and 2 integrons (intI1, intI2), 12 virulence-associated genes, and phylogenetic backgrounds determined by the Clermont method. Among 300 Gram-negative isolates, 135/300 (45.0%) E.coli isolates were confirmed as ESBL producers. Multidrug resistance was detected in 94/95 (98.9%) clinical isolates compared with 15/40 (37.5%) subclinical isolates, and clinical isolates showed significantly higher resistance to fluoroquinolones and aztreonam. Although bla CTX−M predominated overall [90/95 (94.7%) in clinical mastitis and 30/40 (75.0%) in subclinical mastitis], bla TEM and bla SHV were also more frequent among clinical isolates [65/95 (68.4%) and 55/95 (57.9%), respectively] than among subclinical isolates [15/40 (37.5%) for both]. Class 1 integrons were common in both groups and did not differ significantly by disease presentation, whereas dual intI1/intI2 carriage was more frequent among clinical isolates. Clinical isolates showed exclusive detection of colV [20/95 (21.1%) vs. 0/40], whereas subclinical isolates more frequently carried iroN [25/40 (62.5%) vs. 40/95 (42.1%)] and hlyF [30/40 (75.0%) vs. 50/95 (52.6%)]. Phylogroup B2 was more frequent among clinical isolates [45/95 (47.4%) vs. 10/40 (25.0%)], whereas phylogroup F was detected only among subclinical isolates [10/40 (25.0%) vs. 0/95]. In conclusion, ESBL-producing E.coli from clinical and subclinical bovine mastitis showed distinct molecular and phenotypic distributions, with clinical isolates more commonly associated with multidrug resistance, broader ESBL gene carriage, exclusive colV detection, and high-risk phylogenetic backgrounds. These findings support the value of integrated molecular surveillance to inform antimicrobial stewardship and One Health-oriented risk assessment in dairy production systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.